Apyx Medical Corporation (APYX) financial statements (2022 and earlier)

Company profile

Business Address 5115 ULMERTON ROAD
CLEARWATER, FL 33760
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments30,87041,91558,81278,1449,94914,45611,805
Cash and cash equivalents30,87041,91558,81216,4669,94914,45611,805
Short-term investments   61,678   
Receivables21,16317,3289,2205,0154,8574,7332,925
Inventory, net of allowances, customer advances and progress billings6,7784,0515,0685,2126,5266,1585,957
Inventory6,7784,0515,0685,2126,5266,1585,957
Contract with customer, asset100   
Other undisclosed current assets1,8262,7953,6331,1461,2151,1921,355
Total current assets:60,73766,08976,73389,51722,54726,53922,042
Noncurrent Assets
Finance lease, right-of-use asset178437653
Operating lease, right-of-use asset121237350
Property, plant and equipment6,5756,5416,6185,7886,4086,4496,810
Intangible assets, net (including goodwill)   1911,8741,9102,018
Goodwill   185185185185
Intangible assets, net (excluding goodwill)   61,6891,7251,833
Deposits noncurrent assets   7392109123
Other noncurrent assets1,1108073914167103430
Other undisclosed noncurrent assets      25
Total noncurrent assets:7,9848,0228,0126,0938,4418,5719,406
TOTAL ASSETS:68,72174,11184,74595,61030,98835,11031,448
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,9188,78911,8345,3184,4925,0333,882
Accounts payable2,6311,5112,4381,4231,5831,6061,214
Accrued liabilities10,2877,2789,3962,5052,3882,6042,119
Employee-related liabilities   1,390521823549
Debt165238337 239239239
Due to related parties  140    
Other undisclosed current liabilities122126 2,3841,242  
Total current liabilities:13,2059,15312,3117,7025,9735,2724,121
Noncurrent Liabilities
Long-term debt and lease obligation183126561402,4552,6942,934
Long-term debt, excluding current maturities   1402,4552,6942,934
Finance lease, liability18183421
Operating lease, liability 129235
Liabilities, other than long-term debt1,489787519 2021718
Deferred revenue and credits 1418
Deferred revenue1,323621 
Other liabilities166166519    
Derivative instruments and hedges, liabilities    20203 
Other undisclosed noncurrent liabilities    508704971
Total noncurrent liabilities:1,5071,0991,1751402,9833,6153,923
Total liabilities:14,71210,25213,4867,8428,9568,8878,044
Stockholders' equity
Stockholders' equity attributable to parent, including:53,70463,72171,25987,76822,03226,22323,404
Preferred stock     1 
Common stock34343434333127
Additional paid in capital66,22161,06656,70852,22150,49549,62542,859
Retained earnings (accumulated deficit)(12,551)2,62114,51735,513(28,496)(23,434)(19,484)
Other undisclosed stockholders' equity attributable to parent      2
Stockholders' equity attributable to noncontrolling interest305138     
Total stockholders' equity:54,00963,85971,25987,76822,03226,22323,404
TOTAL LIABILITIES AND EQUITY:68,72174,11184,74595,61030,98835,11031,448

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues48,51727,71128,23516,68638,88336,62729,520
Revenue, net16,68638,88336,62729,520
Cost of revenue
(Cost of Goods and Services Sold)
(14,916)(10,207)(9,141)(5,893)(19,122)(18,712)(16,963)
Gross profit:33,60117,50419,09410,79319,76117,91512,557
Operating expenses(48,049)(37,587)(39,963)(24,393)(25,026)(21,707)(19,543)
Other operating expense, net   (203)   
Other undisclosed operating income   203   
Operating loss:(14,448)(20,083)(20,869)(13,600)(5,265)(3,792)(6,986)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(372)6741,03332947(94)1,641
Interest and debt expense(10)(46)(8)(104)   
Loss from continuing operations before equity method investments, income taxes:(14,830)(19,455)(19,844)(13,375)(5,218)(3,886)(5,345)
Other undisclosed income from continuing operations before income taxes10468104   
Loss from continuing operations before income taxes:(14,820)(19,409)(19,836)(13,271)(5,218)(3,886)(5,345)
Income tax expense (benefit)(380)7,5031303,777156(64)(25)
Net loss:(15,200)(11,906)(19,706)(9,494)(5,062)(3,950)(5,370)
Net income attributable to noncontrolling interest2810     
Net loss attributable to parent:(15,172)(11,896)(19,706)(9,494)(5,062)(3,950)(5,370)
Other undisclosed net income available to common stockholders, basic   73,503  13,734
Net income (loss) available to common stockholders, basic:(15,172)(11,896)(19,706)64,009(5,062)(3,950)8,364
Convertible preferred dividends      1,061
Other undisclosed net loss available to common stockholders, diluted    (183)(64)(2,638)
Net income (loss) available to common stockholders, diluted:(15,172)(11,896)(19,706)64,009(5,245)(4,014)6,787

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(15,200)(11,906)(19,706)(9,494)(5,062)(3,950)(5,370)
Comprehensive loss:(15,200)(11,906)(19,706)(9,494)(5,062)(3,950)(5,370)
Comprehensive income, net of tax, attributable to noncontrolling interest2810     
Comprehensive loss, net of tax, attributable to parent:(15,172)(11,896)(19,706)(9,494)(5,062)(3,950)(5,370)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: